共 50 条
- [1] Safety and efficacy of insulin aspart and soluble human insulin in Type 2 diabetes mellitus[J]. MINERVA ENDOCRINOLOGICA, 2012, 37 (04) : 357 - 366Cucinotta, D.Caputo, S.Mannucci, E.Nicolucci, A.Pellegrini, F.Perriello, G.Sbraccia, P.
- [2] A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes[J]. DIABETES CARE, 2004, 27 (05) : 1023 - 1027Bretzel, RGMedding, JArnolds, SLinn, T
- [3] Insulin aspart efficacy and safety compared to human soluble insulin and human premix insulin (30/70) in patients with type 2 diabetes mellitus[J]. DIABETOLOGIA, 2001, 44 : A209 - A209Bretzel, RGMedding, JHirschberger, SLinn, T
- [4] Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: Results from a large, observational study[J]. DIABETES, 2008, 57 : A135 - A135Jang, Hak ChulLee, So RaBech, Ole M.
- [5] An observational study on the efficacy and safety of biphasic insulin aspart 30 among Korean patients with Type 2 diabetes[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S34 - S34Chul, Jang HakHee, Choi SungMyung, Yoo JaeHan, Kim JungMan, Kim DooJung, Kim Dae
- [6] A mufti-center efficacy and safety comparison of insulin aspart, human soluble insulin and human premix insulin,(70/30) in patients with type 2 diabetes mellitus[J]. DIABETES, 2002, 51 : A93 - A93Bretzel, RGHirschberger, SMedding, JLinn, T
- [7] EFFICACY AND SAFETY OF SWITCHING FROM INSULIN DETEMIR TO INSULIN DEGLUDEC WITH MEALTIME INSULIN ASPART IN PEDIATRIC PATIENTS WITH TYPE 1 DIABETES. AN OBSERVATIONAL PROSPECTIVE STUDY[J]. HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 45 - 45Elbarbary, Nancy S.
- [8] A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes[J]. DIABETES OBESITY & METABOLISM, 2007, 9 (05): : 754 - 755Meneilly, G. S.
- [9] Efficacy of biphasic insulin aspart in patients with type 2 diabetes[J]. CLINICAL THERAPEUTICS, 2005, 27 : S57 - S74Halimi, SRaskin, PLiebl, AKawamori, RFulcher, GYan, G
- [10] Efficacy and Safety of Insulin Aspart 30 and Insulin Degludec/Aspart vs. Basal Insulin in Patients with Type 2 Diabetes: A Meta-analysis[J]. DIABETES, 2017, 66 : A252 - A252Mishriky, Basem M.Tanenberg, Robert J.Cummings, Doyle M.
